SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-025793
Filing Date
2010-05-05
Accepted
2010-05-05 16:23:31
Documents
6
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a10-5780_110q.htm 10-Q 792551
2 EX-10.3 a10-5780_1ex10d3.htm EX-10.3 237226
3 EX-10.32 a10-5780_1ex10d32.htm EX-10.32 162041
4 EX-31.1 a10-5780_1ex31d1.htm EX-31.1 13058
5 EX-31.2 a10-5780_1ex31d2.htm EX-31.2 13809
6 EX-32 a10-5780_1ex32.htm EX-32 11554
  Complete submission text file 0001104659-10-025793.txt   1231723
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 10802158
SIC: 2834 Pharmaceutical Preparations